glp 1 oral tablets FDA approves Foundayo, an GLP-1 alternative to Wegovy and Ozempic Novo Nordisk launches its Wegovy

Aetna may cover Wegovy, depending on your specific plan

For comparison, semaglutide user experiences are supported by randomized controlled trial data showing consistent, reproducible effects

Wegovy contains the same active ingredient as Ozempic, but is delivered at a higher maintenance dose (2.4 mg of semaglutide weekly versus 2 mg for Ozempic)

Remember, the medication is not a substitute for a healthy diet it works best alongside good nutrition

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice

The coefficient of variation for orforglipron plasma exposure (AUC and Cmax) across Phase 1 studies was moderate and consistent with typical oral small-molecule drugs, whereas oral semaglutide shows substantially higher variability due to the sensitivity of SNAC-mediated gastric absorption to physiological factors including gastric pH, motility, and volume